journal article·2014-04

Cell-matrix Interactions of Factor IX (FIX)-engineered human mesenchymal stromal cells encapsulated in RGD-alginate vs. Fibrinogen-alginate microcapsules

Bahareh Sayyar, Megan Dodd, Leah Marquez-Curtis, Anna Janowska-Wieczorek, Gonzalo Hortelano

Publisher page

Abstract

The success of cell microencapsulation technology in tissue engineering and protein delivery applications depends on the viability and functionality of the encapsulated cells, which in turn are dependent upon cell/matrix interactions. In this work, we compared the viability of cord blood-derived mesenchymal stromal cells (CB MSCs), engineered to secrete factor IX (FIX) for hemophilia treatment, and encapsulated in arginine-glycine-aspartate (RGD)-alginate versus fibrinogen-alginate microcapsules. We evaluated the effect of the biomimetic matrix on cell attachment, proliferation, and secretion of FIX. Compared with nonsupplemented alginate matrix, RGD-alginate significantly enhanced the viability of the encapsulated MSCs. Further, cells in RGD-alginate displayed distinct attachment morphology, thus suggesting that RGD-alginate can potentially be used for the encapsulation of MSCs in tissue engineering applications that require enhanced cell attachment and viability. However, our data also showed that RGD-alginate microcapsules, in contrast to fibrinogen-alginate microcapsules, did not significantly improve cell proliferation of or FIX secretion by encapsulated MSCs. Our findings suggest that evidence of cell attachment alone may not accurately predict the functionality of cells in biomimetic microcapsules.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Pancreatic function and diabetes · Electrospun Nanofibers in Biomedical Applications · Mesenchymal stem cell research

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (42)

Show source-provided references
1. Aebischer P · ASAIO Trans · 1986 · 32 · 13410.1097/00002480-198609000-00017 ↗
2. Aebischer P · Exp Neurol · 1994 · 126 · 15110.1006/exnr.1994.1053 ↗
3. Augst AD · Macromol Biosci · 2006 · 6 · 62310.1002/mabi.200600069 ↗
4. Bidarra SJ · Biomacromolecules · 2010 · 11 · 195610.1021/bm100264a ↗
5. Bolton-Maggs PHB · Lancet · 2003 · 361 · 180110.1016/S0140-6736(03)13405-8 ↗
6. Boudreau NJ · Biochem J · 1999 · 339 · 48110.1042/bj3390481 ↗
7. 10.1002/bit.26043100510.1002/bit.260431005 ↗
8. Chang PL · Hum Gene Ther · 1993 · 4 · 43310.1089/hum.1993.4.4-433 ↗
9. Chang T · 1972
10. Chang T · 200710.1142/6395 ↗
11. Check E · Nature · 2003 · 423 · 57310.1038/423573a ↗
12. 10.1002/bit.26043071810.1002/bit.260430718 ↗
13. Degala S · Arch Biochem Biophys · 2011 · 505 · 11210.1016/j.abb.2010.08.003 ↗
14. Drury JL · J Biomech Eng · 2005 · 127 · 22010.1115/1.1865194 ↗
15. Duggal S · Tissue Eng Part A · 2009 · 15 · 176310.1089/ten.tea.2008.0306 ↗
16. Evangelista MB · Biomaterials · 2007 · 28 · 364410.1016/j.biomaterials.2007.04.028 ↗
17. García-Martín C · J Gene Med · 2002 · 4 · 21510.1002/jgm.248 ↗
18. Gater A · Thromb Haemost · 2011 · 106 · 39810.1160/TH11-03-0193 ↗
19. Hortelano G · Blood · 1996 · 87 · 509510.1182/blood.V87.12.5095.bloodjournal87125095 ↗
20. Hortelano G · Hum Gene Ther · 1999 · 10 · 128110.1089/10430349950017969 ↗
21. 10.1046/j.1365-2516.2001.00492.x10.1046/j.1365-2516.2001.00492.x ↗
22. Koo J · Int J Artif Organs · 1993 · 16 · 55710.1177/039139889301600710 ↗
23. Lee KY · Prog Polym Sci · 2012 · 37 · 10610.1016/j.progpolymsci.2011.06.003 ↗
24. Lim F · Science · 1980 · 210 · 90810.1126/science.6776628 ↗
25. Liu ZC · Stem Cells Int · 2012 · 2012 · 1
26. Markusen JF · Tissue Eng · 2006 · 12 · 82110.1089/ten.2006.12.821 ↗
27. Marshall E · Panel reviews risks of germ line changes. Science · 2001 · 294 · 2268
28. Nathwani AC · N Engl J Med · 2011 · 365 · 235710.1056/NEJMoa1108046 ↗
29. Orive G · J Control Release · 2009 · 135 · 20310.1016/j.jconrel.2009.01.005 ↗
30. Orive G · J Control Release · 2009 · 135 · 20310.1016/j.jconrel.2009.01.005 ↗
31. Orive G · Biomaterials · 2006 · 27 · 369110.1016/j.biomaterials.2006.02.048 ↗
32. Orive G · Nat Med · 2003 · 9 · 10410.1038/nm0103-104 ↗
33. 10.1016/j.tibtech.2003.11.00410.1016/j.tibtech.2003.11.004 ↗
34. 10.5966/sctm.2011-001910.5966/sctm.2011-0019 ↗
35. Ruoslahti E · Cell · 1986 · 44 · 51710.1016/0092-8674(86)90259-X ↗
36. Sayyar B · J Tissue Eng · 2012
37. 10.1111/j.1365-2141.2004.05106.x10.1111/j.1365-2141.2004.05106.x ↗
38. Shin H · Biomaterials · 2003 · 24 · 435310.1016/S0142-9612(03)00339-9 ↗
39. Thakur A · J Biomed Mater Res B Appl Biomater · 2010 · 94 · 29610.1002/jbm.b.31648 ↗
40. 10.1002/jgm.109810.1002/jgm.1098 ↗
41. 10.1002/jgm.85210.1002/jgm.852 ↗
42. Wong H · Int J Artif Organs · 1986 · 9 · 33510.1177/039139888600900515 ↗